1075-26-9Relevant articles and documents
Synthesis and Evaluation of Indole-Based Autoinducers on Quorum Sensing in Vibrio cholerae
Holoidovsky, Lara,Meijler, Michael M.
, p. 572 - 576 (2020/04/30)
Vibrio cholerae (V. cholerae) uses the autoinducer CAI-1 (cholera autoinducer 1) and several linked quorum sensing systems in order to efficiently sense its ever-changing environment and optimally coordinate population-wide gene expression. Indole has been reported as an important signal that is sensed by V. cholerae, and here, we report the synthesis and evaluation of a focused library of synthetic indole-CAI-1 derivatives as tools to probe quorum sensing (QS) in this human pathogen. Our results show interesting and diverging effects for several conjugates, as compared to CAI-1, on virulence factor production and biofilm formation.
NEAR-INFRARED-ABSORBING DYE, OPTICAL FILTER, AND IMAGING DEVICE
-
Paragraph 0314-0316, (2019/01/04)
Provided is a near-infrared-absorbing dye increasing a visible light transmittance and having a near-infrared blocking characteristic. The near-infrared-absorbing dye has an absorption characteristic measured by dissolving the dye in dichloromethane satisfying the following requirements. ?In an absorption spectrum at a wavelength of 400 to 800 nm, there is a maximum absorption wavelength λmax in a wavelength region of 670 nm or more. ?The following relational expression is established between a maximum absorption constant εA with respect to light with a wavelength of 430 to 550 nm and a maximum absorption constant εB with respect to light with a wavelength of 670 nm or more, where εB/εA≥65. ?In a spectral transmittance curve, an average transmittance of light with a wavelength of 430 to 460 nm is 94.0% or more when a transmittance at the maximum absorption wavelength λmax is set to 1%.
VIRAL REPLICATION INHIBITORS
-
Page/Page column 186; 187, (2013/04/13)
The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.